Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Click Therapeutics, Inc., (Click) announce that the U.S. Food and Drug Administration (FDA) has cleared Rejoyntm (developed as CT-152), the first prescription digital therapeutic authorized for the.
New Report Targets Payer Pain Points for Digital Therapeutics Integration healthleadersmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthleadersmedia.com Daily Mail and Mail on Sunday newspapers.
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients nbcbayarea.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcbayarea.com Daily Mail and Mail on Sunday newspapers.
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients nbcchicago.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcchicago.com Daily Mail and Mail on Sunday newspapers.
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients nbclosangeles.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbclosangeles.com Daily Mail and Mail on Sunday newspapers.